Summary:
The distribution and functional characteristics of in vitro bone marrow (BM) endothelial colonies (CFU-En) were studied in 70 non-Hodgkin's lymphoma (NHL) patients in different phases of the disease to explore the association between CFU-En growth and angiogenesis, and between the number of CFU-En and the presence of hematopoietic and mesenchymal progenitor cells. The mean number of CFU-En/106 BM mononuclear cells seen in remission patients was significantly higher than that seen in newly diagnosed patients (P=0.04), and in normal subjects (P=0.008). Patients with low-grade NHL in remission displayed a higher CFU-En value compared with high-grade NHL (P=0.04). In the autograft group (40 patients), a significant reduction of CFU-En number was detected in the first 4–6 months after transplantation. In remission patients, the CFU-En number positively correlated with the incidence of BM colony-forming unit granulocyte–macrophage (CFU-GM) (P=0.013) and CFU-multilineage (CFU-GEMM) hematopoietic colonies (P=0.044). These in vitro data show that CFU-En numbers increase following standard-dose chemotherapy, thus providing a rationale for further investigating the effects of different cytostatic drugs on BM endothelial cells growth and function.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Prockop DJ . Marrow stromal cells as stem cells for non hematopoietic tissues. Science 1997; 276: 71–74.
Majumdar MK, Thiede MA, Mosca JD et al. Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cell. J Cell Physiol 1998; 176: 57–66.
Rafii S, Shapiro F, Rimarachin J et al. Isolation and characterization of human bone marrow microvascular endothelial cells: hematopoietic progenitor cell adhesion. Blood 1994; 84: 10–19.
Rafii S, Mohle R, Shapiro F et al. Regulation of hematopoiesis by microvascular endothelium. Leuk Lymphoma 1997; 27: 375–378.
Rood PML, Gerritsen WR, Kramer D et al. Adhesion of hematopoietic progenitor cells to human bone marrow or umbilical vein derived endothelial cell lines: a comparison. Exp Hematol 1999; 27: 1306–1314.
Salvucci O, Lei Y, Villalba S et al. Regulation of endothelial cell branching morphogenesis by endogenous chemokine stromal-derived factor-1. Blood 2002; 99: 2703–2711.
Shi Q, Rafii S, Hong-De WM et al. Evidence for circulating bone marrow derived endothelial cells. Blood 1998; 92: 362–367.
Folkman J . Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995; 1: 27–31.
Aguayo A, Kantarjian H, Manshouri et al. Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes. Blood 2000; 96: 2240–2245.
Hamada K, Oike Y, Takakura N et al. VEGF-C signaling pathways through VEGFR-2 and VEGFR-3 in vasculogenesis and hematopoiesis. Blood 2000; 96: 3793–3800.
Vacca A, Ribatti D, Roncali L et al. Bone marrow angiogenesis and progression in multiple myeloma. Br J Haematol 1994; 87: 503–508.
Ribatti D, Vacca A, Nico B et al. Angiogenesis spectrum in the stroma of B-cell non Hodgkin's lymphomas. An immunohistochemical and structural study. Eur J Haematol 1996; 56: 45–53.
Hussong JW, Rodgers GM, Shami PJ . Evidence of increased angiogenesis in patients with acute myeloid leukemia. Blood 2000; 95: 309–313.
Perez-Atayde A, Sallan S, Tedrow U et al. Spectrum of tumor angiogenesis in bone marrow of children with acute lymphoblastic leukemia. Am J Pathol 1997; 150: 815–821.
Deeg HJ . Marrow stroma in MDS: culprit or bystander? Leuk Res 2002; 26: 687–688.
Dominici M, Campioni D, Lanza F et al. Angiogenesis in multiple myeloma: correlation between in vitro endothelial colonies growth (CFU-En) and clinical–biological features. Leukemia 2001; 15: 171–176.
Vega F, Medeiros Lj, Lang Wen-Hua et al. The stromal composition of malignant lymphoid aggregates in bone marrow: variations in architecture and phenotype in different B-cell tumors. Br J Hematol 2002; 117: 569–576.
Castro-Malaspina H, Gay RE, Resnick G et al. Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. Blood 1980; 56: 289–301.
Lanza F, Healy L, Sutherland DR . Structural and functional features of the CD34 antigen: an update. J Biol Regul Homeost Agents 2001; 15: 1–13.
Campioni D, Punturieri M, Bardi A et al. In vitro evaluation of bone marrow angiogenesis in myelodysplastic syndromes: a morphological and functional approach. Leuk Res 2003, (in press).
Dias S, Choy M, Alitalo K, Rafii S . Vascular endothelial growth factor (VEGF)-C signaling through FLT-4 (VEGFR-3) mediates leukemic cell proliferation, survival, and resistance to chemotherapy. Blood 2002; 99: 2179–2184.
Salven P, Teerenhovi L, Joensuu H . A high pretreatment serum vascular endothelial growth factor concentration is associated with poor outcome in non-Hodgkin's lymphoma. Blood 1997; 90: 3167–3172.
Bertolini F, Paolucci M, Peccatori F et al. Angiogenic growth factors and endostatin in non Hodgkin's lymphoma. Br J Haematol 1999; 106: 504–509.
Dominici M, Hofmann TJ, Horwitz EM . Bone marrow mesenchymal cells: biological properties and clinical application. J Biol Regul Homeost Agents 2001; 15: 28–37.
Soligo DA, Lambertenghi Deliliers G, Servida F et al. Haematopoietic abnormalities after autologous stem cell transplantation in lymphoma patients. Bone Marrow Transpl 1998; 21: 15–22.
Lanza F, Campioni D, Moretti S et al. CD34+ cell subsets and long-term culture colony forming cells (LTC-CFC) evaluated on both autologous and normal bone marrow stroma predict long term hematopoietic engraftment in patients receiving autologous peripheral blood stem cell transplantation. Exp Hematol 2001; 29: 1484–1493.
Del Canizo C, Lopez N, Caballero D et al. Haematopoietic damage persists 1 year after autologous peripheral blood stem cell transplantation. Bone Marrow Transpl 1999; 23: 901–905.
D'Arcangelo D, Facchiano F, Barlucchi M et al. Acidosis inhibit endothelial cells apoptosis and function and induces basic fibroblast growth factor and vascular endothelial growth factor expression. Circ Res 2000; 86: 312–318.
Bautz F, Rafii S, Kanz L, Mohle R . Expression and secretion of vascular endothelial growth factor-A by cytokine-stimulated hematopoietic progenitor cells. Possible role in the hematopoietic microenvironment. Exp Hematol 2000; 28: 700–706.
Lenton K . VEGFR-2 (KDR/Flk-1). J Biol Regul Homeost Agents 2002; 16: 227–232.
Wang JM, Kumar S, van Agthoven A et al. Irradiation induces up-regulation of E-9 protein (CD105) in human vascular endothelial cells. Int J Cancer 1995; 62: 791–796.
Huang WQ, Wang QR . Bone marrow endothelial cells secrete thymosin β4 and AcSDKP. Exp Hematol 2001; 29: 12–18.
Guest I, Utrecht J . Bone marrow stem cell protection from chemotherapy by low-molecular-weight compounds. Exp Hematol 2001; 29: 123–137.
Shi Q, Rafii S, Wu MH et al. Evidence for circulating bone marrow-derived endothelial cells. Blood 1998; 92: 362–367.
Lin Y, Weisdorf DJ, Solovey A, Hebbel RP . Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 2000; 105: 71–78.
Murayama T, Tepper OM, Silver M et al. Determination of bone marrow-derived endothelial progenitor cell significance in angiogenic growth factor-induced neo vascularization in vivo. Exp Hematol 2002; 30: 967–972.
Asahara T, Murohara T, Sullivan A et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964–967.
Kalka C, Masuda H, Takahashi T et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularisation. Proc Natl Acad Sci USA 2000; 97: 3422–3427.
Isner JM, Asahara T . Angiogenesis and vasculogenesis as therapeutic strategies for postnatal vascularization. J Clin Invest 1999; 103: 1231–1234.
Crosby JR, Kaminski WE, Shatteman G et al. Endothelial cells of hematopoietic origin make a significant contribution to adult blood vessel formation. Circ Res 2000; 87: 728–730.
Acknowledgements
This work is supported by a grant from CNR/MIUR (Bridge project).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lanza, F., Campioni, D., Punturieri, M. et al. In vitro assessment of bone marrow endothelial colonies (CFU-En) in non-Hodgkin's lymphoma patients undergoing peripheral blood stem cell transplantation. Bone Marrow Transplant 32, 1165–1173 (2003). https://doi.org/10.1038/sj.bmt.1704279
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1704279